Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.
Journal of Affective Disorders April 1, 2023 Nadav Liam Modlin, Tammy M Miller, James J Rucker et al. 30 citations
Recent studies have demonstrated the promise of psilocybin therapies in creating positive changes for those with poor mental health across multiple diagnostic categories, including major depressive disorder (MDD), end-of-life anxiety, and obsessive-compulsive disorder (OCD). While there may be a large population that is eligible to participate in psilocybin therapy based on psychiatric...
DOI: 10.1016/j.jad.2023.01.077 (opens in new tab)
Full text (opens in new tab)
Psychedelic therapy
Optimizing psychedelics
Treatment outcomes
Psilocybin treatment
+3